PMI · Picard Medical Inc.
AI read · Good for PMI
The AI's read
Picard posted Q2 revenue up 39% to $2.95 million, beating a $1.55 million analyst estimate and flipping to about $600,000 gross profit. Shares popped roughly 30% on the print. The company still showed a GAAP loss and recently did a 1-for-50 reverse split, so fundamentals are early-stage. Much of the upside is already priced after the intraday move. We lean bullish because the beat and program progress are idiosyncratic catalysts that can attract financing and buyers. Conviction is capped by the tiny market cap, cash burn, and high post-pop volatility.